Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study-Reference-Cited by-同舟云学术

Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study

Published:2009-06-11 Issue:9 Volume:44 Page:952-963
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Okanoue Takeshi,Itoh Yoshito,Hashimoto Hiroaki,Yasui Kohichiroh,Minami Masahito,Takehara Tetsuo,Tanaka Eiji,Onji Morikazu,Toyota Joji,Chayama Kazuaki,Yoshioka Kentaro,Izumi Namiki,Akuta Norio,Kumada Hiromitsu

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-009-0087-x.pdf

Reference37 articles.

1. Manns MP, McHutchinson JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet. 2001;358:958–65.

2. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonzales FL, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975–82.

3. Hadziyannis S, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, et al. Peginterferon-alfa-2a plus ribavirin combination therapy in chronic hepatitis C. a randomized study of treatment duration and ribavirin dose. Ann Intern Med. 2004;40:346–55.

4. Hiramatsu N, Kurashige N, Oze T, Takehara T, Tamura S, Kasahara A, et al. Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C. Hepatol Res. 2008;38:52–9.

5. Honda T, Katano Y, Urano F, Murayama M, Hayashi K, Ishigami M, et al. Efficacy of ribavirin plus interferon-α in patients aged 60 years with chronic hepatitis C. J Gastroenterol Hepatol. 2007;22:989–95.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variability of the HCV core region and host genetic and epigenetic factors can predict the response to pegylated interferon/ribavirin therapy in genotype 1b hepatitis C patients from Serbia;Archives of Biological Sciences;2023

2. Hepatitis C virus treatment failure: Clinical utility for testing resistance-associated substitutions;World Journal of Hepatology;2021-09-27

3. Hepatitis C genotype 4: A report on resistance‐associated substitutions inNS3,NS5A,andNS5Bgenes;Reviews in Medical Virology;2020-06

4. Frequency of Interferon-Resistance Conferring Substitutions in Amino Acid Positions 70 and 91 of Core Protein of the Russian HCV 1b Isolates Analyzed in the T-Cell Epitopic Context;Journal of Immunology Research;2018

5. Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C;PLOS ONE;2017-08-10